Cannabis use and risk of lung cancer: a case–control study

The aim of the present study was to determine the risk of lung cancer associated with cannabis smoking. A case–control study of lung cancer in adults ≤55 yrs of age was conducted in eight district health boards in New Zealand. Cases were identified from the New Zealand Cancer Registry and hospital databases. Controls were randomly selected from the electoral roll, with frequency matching to cases in 5-yr age groups and district health boards. Interviewer-administered questionnaires were used to assess possible risk factors, including cannabis use. The relative risk of lung cancer associated with cannabis smoking was estimated by logistic regression. In total, 79 cases of lung cancer and 324 controls were included in the study. The risk of lung cancer increased 8% (95% confidence interval (CI) 2–15) for each joint-yr of cannabis smoking, after adjustment for confounding variables including cigarette smoking, and 7% (95% CI 5–9) for each pack-yr of cigarette smoking, after adjustment for confounding variables including cannabis smoking. The highest tertile of cannabis use was associated with an increased risk of lung cancer (relative risk 5.7 (95% CI 1.5–21.6)), after adjustment for confounding variables including cigarette smoking. In conclusion, the results of the present study indicate that long-term cannabis use increases the risk of lung cancer in young adults.

[1]  G. Stevens,et al.  Lung Cancer in New Zealand: Patterns of Secondary Care and Implications for Survival , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  H. Morgenstern,et al.  Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  K. Straif,et al.  Risk of Lung Cancer and Past Use of Cannabis in Tunisia , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  C. Laezza,et al.  Cannabinoids and cancer: pros and cons of an antitumour strategy , 2006, British journal of pharmacology.

[5]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[6]  W. Hall,et al.  Cannabinoids and cancer: causation, remediation, and palliation. , 2005, The Lancet. Oncology.

[7]  A. Sasco,et al.  A case–control study of lung cancer in Casablanca, Morocco , 2002, Cancer Causes & Control.

[8]  M. Guzmán,et al.  Cannabinoids: potential anticancer agents , 2003, Nature Reviews Cancer.

[9]  G. Burci World Health Organization (WHO): Framework Convention on Tobacco Control* , 2003, International Legal Materials.

[10]  B. Martin,et al.  Clinical Consequences of Marijuana , 2002, Journal of clinical pharmacology.

[11]  C. Lathers Endocrine Disruptors: A New Scientific Role for Clinical Pharmacologists? Impact on Human Health, Wildlife, and the Environment , 2002, Journal of clinical pharmacology.

[12]  E. Mark,et al.  Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. , 2001, Cancer research.

[13]  Li Zhu,et al.  Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway1 , 2000, The Journal of Immunology.

[14]  Li Zhu,et al.  D-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway , 2000 .

[15]  E. Mark,et al.  Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. , 1999, Journal of the National Cancer Institute.

[16]  M. Machtay,et al.  Lung and aero-digestive cancers in young marijuana smokers. , 1999, Tumori.

[17]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[18]  Wayne Hall,et al.  Adverse effects of cannabis , 1998, The Lancet.

[19]  M. Roth,et al.  Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. , 1998, Journal of the National Cancer Institute.

[20]  M. Roth,et al.  Airway inflammation in young marijuana and tobacco smokers. , 1998, American journal of respiratory and critical care medicine.

[21]  M. Roth,et al.  Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. , 1997, Chest.

[22]  M. Renneker,et al.  A cytologic evaluation of sputum in marijuana smokers. , 1994, Journal of Family Practice.

[23]  L. Metsch,et al.  Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. , 1994, Journal of psychoactive drugs.

[24]  A. Achour,et al.  Facteurs étiologiques du cancer bronchique primitif en Tunisie. , 1993 .

[25]  M. Hsairi,et al.  [Etiologic factors in primary bronchial carcinoma in Tunisia]. , 1993, La Tunisie medicale.

[26]  Tzu-chin Wu,et al.  Tar, CO and Δ 9-THC delivery from the 1st and 2nd halves of a marijuana cigarette , 1991, Pharmacology Biochemistry and Behavior.

[27]  G. Swan,et al.  Cytomorphologic features of sputum samples from marijuana smokers , 1991, Diagnostic cytopathology.

[28]  J. Rose,et al.  Pulmonary hazards of smoking marijuana as compared with tobacco. , 1988, The New England journal of medicine.

[29]  D. Tashkin,et al.  Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. , 1987, The American review of respiratory disease.

[30]  R. Peto Influence of dose and duration of smoking on lung cancer rates. , 1986, IARC scientific publications.

[31]  J. Robinson,et al.  A comparison of tar, carbon monoxide and pH levels in smoke from marihuana and tobacco cigarettes. , 1982, Canadian journal of public health = Revue canadienne de sante publique.

[32]  E. Wei,et al.  Mutagenic activity of marihuana smoke condensates. , 1979, Cancer letters.

[33]  D. Geddes,et al.  The natural history of lung cancer: a review based on rates of tumour growth. , 1979, British journal of diseases of the chest.

[34]  M. Boutet,et al.  Chronic inhalation of marijuana and tobacco in dogs: pulmonary pathology. , 1976, Research communications in chemical pathology and pharmacology.

[35]  G. B. Gori,et al.  On the Carcinogenicity of Marijuana Smoke , 1975 .

[36]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[37]  R. Doll,et al.  Mortality in Relation to Smoking: Ten Years' Observations of British Doctors , 1964, British medical journal.